Linear Particle Accelerators Industry Growth Expected to Reach $3.48 Billion by 2029 at a CAGR of 6% | Segmentation and Growth Opportunities
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
#How Has the Linear Particle Accelerators Market Growth Performance Trended Historically, And What Lies Ahead?
There has been substantial growth in the linear particle accelerators market in the past few years. The market size is projected to increase from $2.59 billion in 2024 to $2.75 billion in 2025, with a compound annual growth rate (CAGR) of 6.4%. This past growth can be largely ascribed to a rise in demand for cancer therapies, funding and initiatives by the government, improved outcomes of treatments, expansion in healthcare infrastructure, along with collaborations and partnerships.
What Is the Forecast for the Linear Particle Accelerators Market Size Through 2029?
The market size of linear particle accelerators is projected to experience robust growth in the coming years, and is estimated to reach $3.48 billion in 2029, with a compound annual growth rate (CAGR) of 6.0%. Factors contributing to this growth during the forecast period include an increase in the need for precision medicine, a higher rate of proton therapy usage, an aging demographic, emerging markets, and investments in research and development. The forecast period is also likely to observe significant trends such as the adoption of artificial intelligence, broadened use of proton therapy, personalized treatment strategies, less invasive treatment options, and global market growth.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15599&type=smp
What are the Key Market Players in Linear Particle Accelerators Market and How They’re Evolving?
Major companies operating in the linear particle accelerators market are Hitachi Ltd., Mitsubishi Electric Corporation, Toshiba Corporation, Siemens Healthineers, Philips, Beckman Coulter Inc., Carl Zeiss, Elekta AB, Neusoft Corporation, Shinva Medical Instrument Co. Ltd., ALCEN, Laird Technologies, Accuray Incorporated, Brainlab AG, AccSys Technology, Mevion Medical Systems, Viewray Medical Technologies Inc., RefleXion Medical, Panacea Medical Technologies Pvt. Ltd., Altair Technologies, Sordina lort Technologies, MedAustron, LUM GmbH, IBA Group, P-Cure Ltd.
What Are the Primary Growth Drivers in the Linear Particle Accelerators Market?
The surge in emphasis on precision medicine is likely to boost the expansion of the linear particle accelerators market. Precision medicine, an innovative health care approach, provides medical treatments and interventions tailored to each patient’s unique attributes. The rising interest in precision medicine stems from advancements in genomics research and technology, highlighting traditional health care methods’ shortcomings and the potential of custom treatments for improved results. Linear particle accelerators play a crucial role in precision medicine by delivering targeted radiation therapy, which enables precise tumor targeting while reducing harm to nearby healthy tissues. For instance, the U.S-based professional membership organization, the Personalized Medicine Coalition, noted that the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs) in 2022. Out of these 35 therapeutic NMEs, roughly 34%, or 12, are categorized as personalized medicines by the Personalized Medicine Coalition (PMC). Hence, the increased emphasis on precision medicine is propelling the linear particle accelerators market’s growth.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=15599&type=smp
What Are the Leading Segments in the Global Linear Particle Accelerators Industry?
The linear particle accelerators market covered in this report is segmented –
1) By Type: Low-energy Machine, Medium-energy Machine, High-energy Machine
2) By Therapy: Radio Surgery, Radiation Therapy
3) By Applications: Prostate Cancer, Breast Cancer, Lung Cancer, Head and Neck Cancers, Colorectal Cancers, Other Applications
4) By End User: Radiology Clinics, Hospitals, Other End Users
Subsegments:
1) By Low-Energy Machine: Medical Linacs (Linear Accelerators For Radiation Therapy), Research Linacs
2) By Medium-Energy Machine: Industrial Accelerators (Used In Materials Testing, Radiation Processing), Synchrotron Radiation Facilities
3) By High-Energy Machine: High-Energy Physics Research (Accelerators For Particle Collisions, Large Hadron Collider), Nuclear Medicine Accelerators (For Production Of Radioisotopes)
What Are the Key Market Trends in the Linear Particle Accelerators Industry?
Prominent businesses in the field of linear particle accelerators are spearheading innovation by creating state-of-the-art solutions like AI-enabled adaptive computed tomography linear particle accelerators. These advancements are set to transform cancer treatment protocols by offering greater precision, tailored treatments, and real-time imaging for enhanced patient results. Adaptive computed tomography linear particle accelerators powered by AI are frontier medical apparatus that amalgamate artificial intelligence algorithms, computed tomography, and particle acceleration to deliver accurate, customised radiation therapy treatments facilitated by real-time imaging and dynamic treatment planning. For example, in May 2024, Swedish human care company, Elekta, introduced Elekta Evo, an AI-driven, adaptive CT-Linac machine. This linear particle accelerator, uniquely purposed for radiation therapy, offers unparalleled precision and adaptability in cancer treatments to healthcare professionals. Elekta Evo’s superior image quality and online adaptability capabilities provide clinicians with heretofore-unseen precision and flexibility in cancer treatments. Severally, Elekta Evo employs advanced imaging technologies, anatomy-specific programming, and powerful AI to hone treatment plans, spare at-risk organs, and mitigate uncertainty.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/linear-particle-accelerators-global-market-report
What Is the Regional Outlook for the Linear Particle Accelerators Market?
North America was the largest region in the linear particle accelerators market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the linear particle accelerators market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15599
This Report Delivers Insight On:
1. How big is the linear particle accelerators market, and how is it changing globally?
2. Who are the major companies in the linear particle accelerators market, and how are they performing?
3. What are the key opportunities and risks in the linear particle accelerators market right now?
4. Which products or customer segments are growing the most in the linear particle accelerators market?
5. What factors are helping or slowing down the growth of the linear particle accelerators market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.